Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-21-008850
Filing Date
2021-04-15
Accepted
2021-04-15 15:03:51
Documents
44
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 790896
2 ex31-1.htm EX-31.1 10719
3 ex31-2.htm EX-31.2 10722
4 ex32-1.htm EX-32.1 4900
5 logo_001.jpg GRAPHIC 4083
  Complete submission text file 0001493152-21-008850.txt   2615179

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE vapa-20201231.xml EX-101.INS 213874
7 XBRL SCHEMA FILE vapa-20201231.xsd EX-101.SCH 24828
8 XBRL CALCULATION FILE vapa-20201231_cal.xml EX-101.CAL 33677
9 XBRL DEFINITION FILE vapa-20201231_def.xml EX-101.DEF 124977
10 XBRL LABEL FILE vapa-20201231_lab.xml EX-101.LAB 220501
11 XBRL PRESENTATION FILE vapa-20201231_pre.xml EX-101.PRE 180388
Mailing Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419
Business Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419 612-812-2037
CQENS Technologies Inc. (Filer) CIK: 0001479915 (see all company filings)

EIN.: 271521364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55470 | Film No.: 21828299
SIC: 2834 Pharmaceutical Preparations